BioLife Solutions (STU:BJX1) YoY EBITDA Growth

: -106.39% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. BioLife Solutions's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -106.39%.

BioLife Solutions's EBITDA per Share for the three months ended in Dec. 2023 was €-0.07.

BioLife Solutions YoY EBITDA Growth Historical Data

The historical data trend for BioLife Solutions's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLife Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

108.92

-73.11

-1,256.25

-36.76

-87.55

BioLife Solutions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															719.25	-202.78	91.66	-248.08	-106.39

BioLife Solutions YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

BioLife Solutions's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.949	-	-0.506)	/	\| -0.506 \|
=	-87.55 %

BioLife Solutions's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.074	-	1.158)	/	\| 1.158 \|
=	-106.39 %

BioLife Solutions YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of BioLife Solutions's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLife Solutions (STU:BJX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioLife Solutions Inc (STU:BJX1) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

BLFS:USA BJX1:Germany

Address

3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021

Website

https://www.biolifesolutions.com

BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.

BioLife Solutions (STU:BJX1) Headlines

No Headlines